203 related articles for article (PubMed ID: 20300195)
1. A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene.
Chatagnon A; Ballestar E; Esteller M; Dante R
PLoS One; 2010 Mar; 5(3):e9665. PubMed ID: 20300195
[TBL] [Abstract][Full Text] [Related]
2. Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells.
Won Jeong K; Chodankar R; Purcell DJ; Bittencourt D; Stallcup MR
Mol Endocrinol; 2012 Jun; 26(6):955-66. PubMed ID: 22543272
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha and the activating protein-1 complex cooperate during insulin-like growth factor-I-induced transcriptional activation of the pS2/TFF1 gene.
Baron S; Escande A; Albérola G; Bystricky K; Balaguer P; Richard-Foy H
J Biol Chem; 2007 Apr; 282(16):11732-41. PubMed ID: 17317669
[TBL] [Abstract][Full Text] [Related]
4. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins.
Sun JM; Spencer VA; Li L; Yu Chen H; Yu J; Davie JR
Exp Cell Res; 2005 Jan; 302(1):96-107. PubMed ID: 15541729
[TBL] [Abstract][Full Text] [Related]
5. The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein.
Martin V; Ribieras S; Rio MC; Dante R
Biol Chem; 1998; 379(4-5):409-16. PubMed ID: 9628331
[TBL] [Abstract][Full Text] [Related]
6. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
7. Transient cyclical methylation of promoter DNA.
Kangaspeska S; Stride B; Métivier R; Polycarpou-Schwarz M; Ibberson D; Carmouche RP; Benes V; Gannon F; Reid G
Nature; 2008 Mar; 452(7183):112-5. PubMed ID: 18322535
[TBL] [Abstract][Full Text] [Related]
8. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers.
Martin V; Ribieras S; Song-Wang XG; Lasne Y; Frappart L; Rio MC; Dante R
J Cell Biochem; 1997 Apr; 65(1):95-106. PubMed ID: 9138084
[TBL] [Abstract][Full Text] [Related]
9. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
10. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1.
Wagner S; Weber S; Kleinschmidt MA; Nagata K; Bauer UM
J Biol Chem; 2006 Sep; 281(37):27242-50. PubMed ID: 16861234
[TBL] [Abstract][Full Text] [Related]
11. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.
Krieg AJ; Krieg SA; Ahn BS; Shapiro DJ
J Biol Chem; 2004 Feb; 279(6):5025-34. PubMed ID: 14617632
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
13. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
14. Ectopic Methylation of a Single Persistently Unmethylated CpG in the Promoter of the Vitellogenin Gene Abolishes Its Inducibility by Estrogen through Attenuation of Upstream Stimulating Factor Binding.
Kallenberger L; Erb R; Kralickova L; Patrignani A; Stöckli E; Jiricny J
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31548262
[TBL] [Abstract][Full Text] [Related]
15. pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor alpha, an estrogen-responsive element, and the activator protein 1 response element.
Barkhem T; Haldosén LA; Gustafsson JA; Nilsson S
Mol Pharmacol; 2002 Jun; 61(6):1273-83. PubMed ID: 12021387
[TBL] [Abstract][Full Text] [Related]
16. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
17. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
[TBL] [Abstract][Full Text] [Related]
18. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells.
John Mary DJS; Sikarwar G; Kumar A; Limaye AM
Mol Cell Endocrinol; 2020 Mar; 504():110701. PubMed ID: 31926189
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
Auriol E; Billard LM; Magdinier F; Dante R
Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
